Parexel, a CRO, released a new web-based platform to be used in late-phase clinical research to help users meet regulatory guidelines and ensure high quality data. The new product combines the expertise of Parexel’s existing Peri Approval Clinical Excellence (PACE) team with the eClinical capabilities of Perceptive Informatics, Parexel’s technology subsidiary. The platform allows for a variety of eClinical services, such as clinical trial management systems, electronic data capture, randomization and trial supply management, and electronic patient-reported outcomes, to be incorporated in late-phase studies.

"Post-approval studies have continued to expand measurably in number, size, and complexity in recent years. As a result, biopharmaceutical companies require much greater efficiency in managing the high volume throughput of data while controlling the costs related to these programs. We are focused on helping clients achieve greater efficiency by gathering more data at a significantly lower cost per patient," said Carol Collins, Ph.D., corporate vice president and worldwide head of PACE, in a statement.